×
About 850 results

ALLMedicine™ Giardiasis Center

Research & Reviews  300 results

Esophageal String Test in Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT02008903

Aug 1st, 2022 - Eosinophilic esophagitis (EoE) is an increasingly recognized rare disease of children and adults characterized by symptoms including nausea, vomiting, abdominal pain, dysphagia and food impaction that occur in conjunction with esophageal eosinophi...

Evaluation of the Diagnostic Role of Enteroscopy in Small Intestinal Diseases at Al-Rajhi University Hospital
https://clinicaltrials.gov/ct2/show/NCT05470946

Jul 22nd, 2022 - The small bowel is vital for digestion and absorption and is located between the stomach and large bowel. Because of its anatomical position, the small bowel was originally thought to be a "blind area" beyond the reach of ordinary endoscopic exami...

Protein-losing Enteropathy as a Complication and/or Differential Diagnosis of Common Va...
https://doi.org/10.1007/s10875-022-01299-1
Journal of Clinical Immunology; Lefèvre G, Germain N et. al.

Jun 24th, 2022 - As protein-losing enteropathy (PLE) can lead to hypogammaglobulinemia and lymphopenia, and since common variable immunodeficiency (CVID) is associated with digestive complications, we wondered if (1) PLE could occur during CVID and (2) specific fe...

3-nitroimidazo1,2-bpyridazine as a novel scaffold for antiparasitics with sub-nanomolar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213561
International Journal for Parasitology. Drugs and Drug Re... Zheng Y, Müller J et. al.

Jun 19th, 2022 - As there is a continuous need for novel anti-infectives, the present study aimed to fuse two modes of action into a novel 3-nitroimidazo[1,2-b]pyridazine scaffold to improve antiparasitic efficacy. For this purpose, we combined known structural el...

Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295539
Antimicrobial Agents and Chemotherapy; Michaels SA, Hulverson MA et. al.

Jun 16th, 2022 - A phenotypic screen of the ReFRAME compound library was performed to identify cell-active inhibitors that could be developed as therapeutics for giardiasis. A primary screen against Giardia lamblia GS clone H7 identified 85 cell-active compounds a...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  11 results

Esophageal String Test in Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT02008903

Aug 1st, 2022 - Eosinophilic esophagitis (EoE) is an increasingly recognized rare disease of children and adults characterized by symptoms including nausea, vomiting, abdominal pain, dysphagia and food impaction that occur in conjunction with esophageal eosinophi...

Evaluation of the Diagnostic Role of Enteroscopy in Small Intestinal Diseases at Al-Rajhi University Hospital
https://clinicaltrials.gov/ct2/show/NCT05470946

Jul 22nd, 2022 - The small bowel is vital for digestion and absorption and is located between the stomach and large bowel. Because of its anatomical position, the small bowel was originally thought to be a "blind area" beyond the reach of ordinary endoscopic exami...

Auranofin for Giardia Protozoa
https://clinicaltrials.gov/ct2/show/NCT02736968

Jun 3rd, 2022 - This is a phase IIa, randomized, placebo-controlled, single-blinded superiority treatment study in males and non-pregnant females, 18 to 65 years of age who are in good health. This study is designed to compare placebo to once daily doses of 6mg a...

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
https://clinicaltrials.gov/ct2/show/NCT04827537

Apr 14th, 2022 - The randomized, double-blinded, placebo-controlled clinical study will be conducted by the Uzbek State University of Physical Education and Sport, Institute of the Chemistry of Plant Substances named acad. S. Yu. Yunusov and Republican Specialized...

Stool Transplants to Treat Refractory Clostridium Difficile Colitis
https://clinicaltrials.gov/ct2/show/NCT02127398

Sep 20th, 2021 - Recurrent colitis due to Clostridium difficile results from disruption of the normal gut flora, and is very difficult to treat. It is now clear that restoration of the normal gut flora is the most effective way to treat recurrent C. difficile coli...

see more →

News  16 results

CDC Mandates Measles Quarantine for Afghanistan Evacuees
https://www.medscape.com/viewarticle/959222

Sep 22nd, 2021 - Evacuees of Afghanistan who have arrived in the United States must be vaccinated against measles and undergo quarantine for 21 days, according to a health advisory issued September 20 by the Centers for Disease Control and Prevention (CDC). At the...

Alcohol and Metronidazole Interaction: Real or Fake?
https://www.medscape.com/viewarticle/917065

Aug 21st, 2019 - An otherwise healthy 32-year-old man is diagnosed with giardiasis and prescribed metronidazole. He is scheduled to be the best man at his brother's wedding in 3 days. You must Log In to answer this question

Fast Five Quiz: Are You Prepared to Confront Parasitic Infections?
https://reference.medscape.com/viewarticle/882224_6

Jun 29th, 2017 - Standard treatment for giardiasis consists of antibiotic therapy. Metronidazole is the most commonly prescribed antibiotic for this condition. However, metronidazole use has been associated with significant failure rates in clearing parasites from...

VIDEO: Infectious enteritis quadrupled short-term risk of IBS
https://www.mdedge.com/familymedicine/article/132135/infectious-diseases/video-infectious-enteritis-quadrupled-short-term
Internal Medicine News; Amy Karon

Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.

VIDEO: Infectious enteritis quadrupled short-term risk of IBS
https://www.mdedge.com/gihepnews/article/132135/infectious-diseases/video-infectious-enteritis-quadrupled-short-term-risk
Amy Karon, MDedge News

Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.

see more →

Patient Education  5 results see all →